These syndromes are characterized by monocytopenia, neutropenia, B-, dendritic- and NK cell lymphopenia and up to 80% of patients with innate GATA2 mutations develop myelodysplastic syndrome (MDS)/ acute myeloid leukemia (AML). The gene discussed is GATA2; the disease is Decreased total monocyte count.